top of page
News
Press Releases
Inflection Biosciences to Present at Annual BioPharm America International Partnering Conference
Dublin, Ireland, September 15, 2014 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...
Sep 15, 2014
Inflection Biosciences Announces Poster Presentation at the 2014 AACR Annual Meeting
Dublin, Ireland, March 24, 2014 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...
Mar 24, 2014
Inflection Biosciences Announces Poster Presentation at the 2013 AACR-NCI-EORTC Conference
Dublin, Ireland, October 17, 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...
Oct 17, 2013
Dr Michael O’Neill, Inflection Biosciences' Director of R&D interviewed by Pharma Television
Dublin, Ireland, 16 August 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...
Aug 16, 2013
Inflection Licenses Preclinical Oncology Programs from the Spanish National Cancer Research Centre
Dublin, Ireland, June 4, 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...
Jun 4, 2013
Inflection Biosciences Selected to Present at International Investor Forum
Dublin, Ireland, November 21, 2012 Inflection Biosciences limited was selected as one of 25 Irish companies to present at the 5th...
Nov 21, 2012
Inflection Biosciences to attend 24th Annual EORTC-NCI-AACR Symposium
Dublin, Ireland, November 6, 2012 Inflection Biosciences to attend the the 24th Annual EORTC-NCI-AACR Symposium on Molecular Targets and...
Nov 6, 2012
bottom of page